Gene polymorphisms in calcium-calmodulin pathway: Focus on cardiovascular disease

Area of Science:

• Cardiology
• Genetics
• Molecular Biology

Background:

• Cardiovascular disease (CVD) is a leading cause of death globally, with lifestyle and genetic factors contributing to its etiology.
• Calcium signaling in the heart is critical for excitation-contraction coupling, with calmodulin (CaM) playing a key regulatory role.
• Polymorphic variants in proteins can predispose individuals to complex diseases, suggesting a genetic link to CVD.

Purpose of the Study:

• To investigate the role of calmodulin pathway genetic variants in cardiovascular disease predisposition.
• To analyze polymorphisms in calmodulin isoforms (CaM1, CaM2, CaM3) and associated proteins.
• To determine the association between these polymorphisms and the risk of myocardial infarction.

Main Methods:

• Literature review of studies on calmodulin pathway proteins and their polymorphisms.
• Analysis of genetic variants within CaM1, CaM2, and CaM3 pathways.
• Examination of existing research linking these polymorphisms to cardiovascular disease.

Main Results:

• The review synthesizes data on various polymorphisms within the calmodulin pathway.
• Specific polymorphic variants are identified as potential predisposing factors for cardiovascular pathologies.
• The association between certain calmodulin-related genetic variations and myocardial infarction risk is explored.

Conclusions:

• Genetic variations in the calmodulin pathway are implicated in cardiovascular disease risk.
• Understanding these polymorphisms is crucial for identifying individuals predisposed to myocardial infarction.
• Further research into calmodulin genetics can enhance personalized risk assessment for cardiovascular conditions.